EUDA Health Holdings Limited

NASDAQ:EUDA

Medical - Care Facilities

Healthcare
$17.70 +14.19%

+$2.20 today

Market cap
$53.00M
Beta
0.59
P/E (TTM)
-7.9
EPS (TTM)
-$1.79
52W Low $5.26High $71.20

Volume 0.04M

Average 0.02M

EUDA Net Income

Bottom-line profit, the starting point for calculating cash from operations.

EUDA Health Holdings LimitedNASDAQ: EUDA

Net Income · Q2 FY2026 · quarter ended Jun 2026

Net income declines year over year

Q2 FY2026 net income of $397.5K (cash outflow) fell 34.0% year over year, ahead of the -1730.1% change in trailing-twelve-month net income. Sequentially, it rose 0.0% from the prior quarter. Over 3 fiscal years it compounded at -52.0% a year.

Context

  • Net income amounted to 40.6% of revenue in FY2025, down 398.3 pp from a year earlier.
  • Net income grew in size in 1 of the last 3 fiscal years.
  • FY2025 was the smallest annual figure in the 4 fiscal years shown.

What to watch

Whether net income reaches the consensus estimate from 1 analysts of $2.97M (+207.4%) for the fiscal year ending Dec 2026, a step up from the -84.3% reported in FY2025.

Sources:Cash Flow Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterJun 2026
-$397.5K+0.0% QoQ
Last fiscal yearDec 2025
-$2.77M-84.3% YoY
LTMJun 2026
-$4.35M-1730.1% YoY
Net Income past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-34.0%+271.7%+305.7 pp
1 year-84.3%+207.4%+291.7 pp
3-year CAGR-52.0%——
5-year CAGR——
10-year CAGR——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

Net Income history

USD · from the cash flow

Latest · FY2025
(2.77M) USD
Year-over-year change
+84.3%
Reported Analyst consensus estimate

Net Income vs competitors

How EUDA compares with its peers on the latest reported figures

  • Peers report in different currencies, so net income is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of -1730.1% is the lowest of 8, against a peer median of +10.4%.
  • Net income amounts to 35.7% of revenue for EUDA, versus a peer median of 161.8%.
EUDA Competitors
Net Income for EUDA and competitors
Company Period LTM YoY 3-year CAGR% of revenue
GUTSFractyl Health, Inc. Common StockLTM Mar 2026$108M USD+21.2%+44.8%—
AMWLAmerican Well CorporationLTM Mar 2026$86.67M USD-44.1%-29.4%36.5%
ATYRaTyr Pharma, Inc.LTM Mar 2026$70.03M USD+10.4%+17.8%36859.5%
DTILPrecision BioSciences, Inc.LTM Mar 2026$43.6M USD+98.3%-25.7%96.7%
HYPRHyperfine, Inc.LTM Mar 2026$34.78M USD-13.7%-21.4%226.9%
ZTEKZentek Ltd.LTM Mar 2026CA$9.78M CAD+14.2%-12.1%5885.5%
FONRFONAR CorporationLTM Mar 2026$8.27M USD-11.1%-14.8%7.8%
EUDAEUDA Health Holdings LimitedLTM Jun 2026$4.35M USD-1730.1%-52.0%35.7%
Peer median (excluding EUDA) —+10.4%-14.8%161.8%

Competitors are the stored peer set for EUDA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income900.4K(24.95M)(8.44M)(17.6M)(2.77M)
Depreciation & Amortization264.1K172.02K119.35K173.22K406.48K
Deferred Income Tax(27.68K)(48.23K)0(4.38K)4.38K
Stock-Based Compensation00000
Change in Working Capital1.18M1.12M531.2K194.93K(230.03K)
Accounts Receivables(263.95K)(174.82K)(32.97K)82.35K(166.99K)
Inventory03.69M0(126.27K)45.43K
Accounts Payables1.38M(1.13M)1.27K15.99K(12.95K)
Other Working Capital68.04K(1.27M)562.89K222.86K(95.52K)
Other Non-Cash Items(1.87M)22.18M4.87M15.21M160.35K
Operating Cash Flow443.92K(1.53M)(2.92M)(2.03M)(2.43M)
Capital Expenditures(1.96K)(18.14K)(5)(116.03K)(104.45K)
Acquisitions (Net)(354.23K)(3.41K)016.3K0
Purchases of Investments00000
Sales of Investments00000
Other Investing Activities(355.08K)(246.66K)5(48.03K)(27.19K)
Investing Cash Flow(356.18K)(268.21K)0(147.77K)(104.45K)
Debt Repayment(6.69K)1.4M1.44M2.16M2.22M
Common Stock Issued01.1M790K50K100K
Common Stock Repurchased00000
Dividends Paid00000
Other Financing Activities(161.69K)(9.47K)121.88K115.14K234.46K
Financing Cash Flow(168.37K)2.49M2.35M2.32M2.55M
Effect of Forex Changes19.87K(99.42K)(21.53K)(101.66K)88.49K
Net Change in Cash(60.77K)594.49K(586.93K)40.05K107.54K
Free Cash Flow441.96K(1.54M)(2.92M)(2.15M)(2.53M)

EUDA Health Holdings Limited

NASDAQ:EUDA

Intrinsic Alpha fair value

Locked

Current Price

$17.70

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.